BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23292756)

  • 1. The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer.
    Santillán-Benítez JG; Mendieta-Zerón H; Gómez-Oliván LM; Torres-Juárez JJ; González-Bañales JM; Hernández-Peña LV; Ordóñez-Quiroz A
    J Clin Lab Anal; 2013 Jan; 27(1):12-20. PubMed ID: 23292756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
    Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
    Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adiponectin and leptin levels in Taiwanese breast cancer patients.
    Chen DC; Chung YF; Yeh YT; Chaung HC; Kuo FC; Fu OY; Chen HY; Hou MF; Yuan SS
    Cancer Lett; 2006 Jun; 237(1):109-14. PubMed ID: 16019138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
    Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
    Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
    Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
    Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between body mass index and a body shape index with adiponectin/leptin ratio and markers of glucose metabolism among adolescents.
    Giudici KV; Martini LA
    Ann Hum Biol; 2017 Sep; 44(6):489-494. PubMed ID: 28482705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a walking intervention using mobile technology and interactive voice response on serum adipokines among postmenopausal women at increased breast cancer risk.
    Llanos AA; Krok JL; Peng J; Pennell ML; Vitolins MZ; Degraffinreid CR; Paskett ED
    Horm Cancer; 2014 Apr; 5(2):98-103. PubMed ID: 24435584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study.
    Akyol M; Demir L; Alacacioglu A; Ellidokuz H; Kucukzeybek Y; Yildiz Y; Gumus Z; Bayoglu V; Yildiz I; Salman T; Varol U; Kucukzeybek B; Demir L; Dirican A; Sutcu R; Tarhan MO
    Chemotherapy; 2016; 61(2):57-64. PubMed ID: 26571369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation of leptin and adiponectin with breast density among premenopausal women.
    Maskarinec G; Woolcott C; Steude JS; Franke AA; Cooney RV
    Eur J Cancer Prev; 2010 Jan; 19(1):55-60. PubMed ID: 19927000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
    Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
    Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women.
    Gupta V; Mishra S; Mishra S; Kumar S; Gupta V
    Immunol Lett; 2018 Apr; 196():63-67. PubMed ID: 29410303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial.
    Llanos AA; Peng J; Pennell ML; Krok JL; Vitolins MZ; Degraffinreid CR; Paskett ED
    J Clin Endocrinol Metab; 2014 Feb; 99(2):625-32. PubMed ID: 24423335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
    Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
    Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of obesity with serum concentrations of leptin, CRP and IL-6 in breast cancer survivors.
    Babaei Z; Moslemi D; Parsian H; Khafri S; Pouramir M; Mosapour A
    J Egypt Natl Canc Inst; 2015 Dec; 27(4):223-9. PubMed ID: 26462194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3.
    Maccio G; Goussot V; Berriolo-Riedinger A; Riedinger JM
    Ann Biol Clin (Paris); 2017 Aug; 75(4):431-441. PubMed ID: 28751288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors.
    Sadim M; Xu Y; Selig K; Paulus J; Uthe R; Agarwl S; Dubin I; Oikonomopoulou P; Zaichenko L; McCandlish SA; Van Horn L; Mantzoros C; Ankerst DP; Kaklamani VG
    Cancer; 2017 Jul; 123(13):2413-2421. PubMed ID: 28195643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.
    Provatopoulou X; Georgiou GP; Kalogera E; Kalles V; Matiatou MA; Papapanagiotou I; Sagkriotis A; Zografos GC; Gounaris A
    BMC Cancer; 2015 Nov; 15():898. PubMed ID: 26560078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.